首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Role of GSTM1 and GSTT1 Polymorphism: Susceptibility to Oral Submucous Fibrosis in the North Indian Population.
【24h】

Role of GSTM1 and GSTT1 Polymorphism: Susceptibility to Oral Submucous Fibrosis in the North Indian Population.

机译:GSTM1和GSTT1多态性的作用:在北印度人口中对口腔粘膜下纤维化的易感性。

获取原文
获取原文并翻译 | 示例

摘要

Molecular epidemiological studies have provided evidence that individual susceptibility to cancer is mediated by both genetic and environmental factors. Several allelic variants of polymorphic glutathione s-transferases (GSTs) show impaired enzyme activity and are suspected to increase the host's susceptibility to various cancers. To determine the association of GST variants with the risk of oral submucous fibrosis (OSF), the distribution of polymorphisms in GSTM1 and GSTT1 was studied in 90 OSF patients and 130 healthy controls. Genotypic analysis was performed by multiplex PCR. The relationship between the null genotypes and the risk of OSF was assessed by means of odds ratios (OR) with 95% confidence intervals (CI) calculated by logistic regression. The frequency of both the GSTM1 and GSTT1 null genotypes was higher in the OSF cases than in the controls. The prevalence of the GSTM1 null genotype in the OSF cases was 46.6% as compared to 29.2% in the controls (OR 2.12, 95% CI 1.2-3.9) and GSTT1 null was 24.4% in the OSF cases versus 10.7% in the controls (OR 2.68, 95% CI 1.22-5.96). There was evidence of an increased risk with the absence of both genotypes (7.5-fold; OR 7.5, 95% CI 2.3-24). Our findings suggest that the GSTM1 and GSTT1 null genotypes, separately or in combination, increase the risk of developing OSF in the North Indian population.
机译:分子流行病学研究已提供证据表明,个体对癌症的易感性是由遗传和环境因素介导的。多态性谷胱甘肽S-转移酶(GST)的几种等位基因变体显示酶活性受损,并被怀疑会增加宿主对各种癌症的敏感性。为了确定GST变异与口腔粘膜下纤维化(OSF)的风险之间的关系,在90例OSF患者和130个健康对照中研究了GSTM1和GSTT1中的多态性分布。通过多重PCR进行基因型分析。无效基因型与OSF风险之间的关系通过逻辑回归计算的比值比(OR)和95%置信区间(CI)进行评估。 OSF病例中GSTM1和GSTT1无效基因型的频率均高于对照。 OSF病例中GSTM1无效基因型的患病率为46.6%,而对照组为29.2%(OR 2.12,95%CI 1.2-3.9),GSF1无效基因型在OSF病例中为24.4%,而对照组为10.7%(或2.68,95%CI 1.22-5.96)。有证据表明,两种基因型均不存在时风险增加(7.5倍; OR 7.5,95%CI 2.3-24)。我们的发现表明,GSTM1和GSTT1无效基因型,单独或组合使用,会增加北印度人口发生OSF的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号